Genetic Variants in Decorin and Lumican and Ovarian Cancer Risk
2011
n=5017
publication
10 minutes
Evidence: moderate
Amankwah Ernest K., Wang Qinggang, Schildkraut Joellen M., Tsai Ya-Yu, Ramus Susan J., Fridley Brooke L., Beesley Jonathan, Johnatty Sharon E., Webb Penelope M., Chenevix-Trench Georgia, Dale Laura C., Lambrechts Diether, Amant Frederic, Despierre Evelyn, Vergote Ignace, Gayther Simon A., Gentry-Maharaj Aleksandra, Menon Usha, Chang-Claude Jenny, Wang-Gohrke Shan, Anton-Culver Hoda, Ziogas Argyrios, Dörk Thilo, Dürst Matthias, Antonenkova Natalia, Bogdanova Natalia, Brown Robert, Flanagan James M., Kaye Stanley B., Paul James, Bützow Ralf, Nevanlinna Heli, Campbell Ian, Eccles Diana M., Karlan Beth Y., Gross Jenny, Walsh Christine, Pharoah Paul D. P., Song Honglin, Krüger Kjær Susanne, Høgdall Estrid, Høgdall Claus, Lundvall Lene, Nedergaard Lotte, Kiemeney Lambertus A. L. M., Massuger Leon F. A. G., van Altena Anne M., Vermeulen Sita H. H. M., Le Nhu D., Brooks-Wilson Angela, Cook Linda S., Phelan Catherine M., Cunningham Julie M., Vachon Celine M., Vierkant Robert A., Iversen Edwin S., Berchuck Andrew, Goode Ellen L., Sellers Thomas A., Kelemen Linda E.
Title
Genetic Variants in Decorin and Lumican and Ovarian Cancer Risk
Hypothesis
Inherited variation in DCN and LUM may influence the risk of serous epithelial ovarian cancer.
Conclusion
Variants in DCN and LUM are not directly associated with serous epithelial ovarian cancer, and further confirmation of possible effect modification by non-genetic factors is needed.